Discussion Paper: Biologic medicines and biosimilars in the Australian landscape - The challenges and the opportunities

By Ric Morgan

In brief

Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars.

As part of this engagement, we highlight a number of key issues for discussion and comment.

>> Download a PDF copy of the Discussion Paper.